Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 117 (RPL21P117) is a processed pseudogene related to the ribosomal protein L21 (RPL21) gene. Pseudogenes are segments of DNA that resemble functional genes but do not encode functional proteins due to mutations or truncations. RPL21P117 is not a protein-coding gene and does not have any documented molecular function, biological pathway association, or role as a therapeutic target. There are multiple RPL21 pseudogenes dispersed throughout the genome, and they are not considered functionally relevant for ribosomal activity or as drug targets[4][5]. This entry is not a functional protein or receptor and therefore is not considered a therapeutic target in pharmacology or molecular medicine. The actual therapeutically relevant gene/protein is Ribosomal protein L21 (RPL21), not its pseudogenes. RPL21 itself is a structural component of the 60S ribosomal subunit and is associated with diseases such as hypotrichosis simplex when mutated[4][5]. Aliases given (RPL21_53_1439, RPL21P117) reflect alternative ways of cataloging this pseudogene but do not correspond to a functional entity. RPL21P117 is a pseudogene, not a therapeutic target, and does not participate in known biological functions, disease pathogenesis, or drug pathways[4][5]. If the intended query was for the functional ribosomal protein, refer instead to "Ribosomal protein L21 (RPL21)"[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 117 (RPL21P117).